Previous Close | 0.1500 |
Open | 1.4500 |
Bid | 0.0000 |
Ask | 4.8000 |
Strike | 310.00 |
Expire Date | 2024-10-18 |
Day's Range | 0.1500 - 5.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 24 |
Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.